SILO实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Stats
今日成交量	14 087.00
平均成交量	203 501
市值	5.26M
EPS	$0 ( 2024-03-25 )
下一个收益日期	( $0 ) 2024-06-24
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.570
ATR14	$0.0270 (1.46%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-05	Weisblum Eric	Buy	400	Common Stock
2024-04-04	Weisblum Eric	Buy	600	Common Stock
2024-04-01	Weisblum Eric	Buy	1 100	Common Stock
2024-03-28	Weisblum Eric	Buy	3 408	Common Stock
2023-12-20	Weisblum Eric	Buy	200	Common Stock

INSIDER POWER
100.00
Last 55 transactions
Buy: 22 165 052 \| Sell: 3 696 660

Silo Pharma, Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Silo Pharma, Inc. 财务报表

Annual	2023
营收:	$72 102.00
毛利润:	$-805 361 (-1 116.97 %)
EPS:	$-1.200

FY	2023
营收:	$72 102.00
毛利润:	$-805 361 (-1 116.97 %)
EPS:	$-1.200

FY	2022
营收:	$72 102.00
毛利润:	$66 264.00 (91.90 %)
EPS:	$-1.710

FY	2021
营收:	$71 264.00
毛利润:	$66 260.00 (92.98 %)
EPS:	$2.00

Financial Reports:

No articles found.

Silo Pharma, Inc.

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University of Maryland, The Regents of the University of California, and Columbia University. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.